Possible roles of B lymphocyte activating factor of the tumour necrosis factor family in vitiligo autoimmunity (Q39817453)

14 September 2017

title

Possible roles of B lymphocyte activating factor of the tumour necrosis factor family in vitiligo autoimmunity (English)

1 reference

14 September 2017

0 references

0 references

1 reference

Xiran Lin

1 reference

14 September 2017

Huang Tian

series ordinal

1 reference

14 September 2017

Meng Xianmin

series ordinal

1 reference

14 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21075543

26 August 2024

publication date

13 November 2010

1 reference

full work available at URL

14 September 2017

https://api.elsevier.com/content/article/PII:S0306987710004470?httpAccept=text/xml

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

https://api.elsevier.com/content/article/PII:S0306987710004470?httpAccept=text/plain

26 August 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

1 reference

14 September 2017

1 reference

14 September 2017

1 reference

14 September 2017

page(s)

339-342

1 reference

14 September 2017

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Psychologic effects of vitiligo: a critical incident analysis

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Update on skin repigmentation therapies in vitiligo

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

B-lymphocyte contributions to human autoimmune disease

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Travelling with the BAFF/BLyS family: are we there yet?

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

T cell costimulation by the TNF ligand BAFF.

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Detection of Antibodies to Melanocytes in Vitiligo by Specific Immunoprecipitation

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Coexistence and relationship of antikeratinocyte and antimelanocyte antibodies in patients with non-segmental-type vitiligo

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Correlation between vitiligo antibodies and extent of depigmentation in vitiligo

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Relation Between the Incidence and Level of Pigment Cell Antibodies and Disease Activity in Vitiligo

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

In Vivo Destruction of Melanocytes by the IgG Fraction of Serum from Patients with Vitiligo

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Apoptosis of melanocytes in vitiligo results from antibody penetration

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo.

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

HLA-A2 Restricted, Melanocyte-Specific CD8+ T Lymphocytes Detected in Vitiligo Patients are Related to Disease Activity and are Predominantly Directed Against MelanA/MART1

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

An immunohistological study of cutaneous lymphocytes in vitiligo.

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Autoimmunity as an aetiological factor in vitiligo

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Peripheral blood lymphocyte imbalance in Koreans with active vitiligo

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Characterization of lymphocyte surface markers in patients with vitiligo

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Autoimmunity: increasing suspects in the CD4+ T cell lineup

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

B cell maturation antigen, the receptor for a proliferation-inducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

BAFF augments certain Th1-associated inflammatory responses.

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Soluble interleukin 2 receptor and interleukin 1alpha in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Relationship between levels of soluble interleukin-2 receptors and the types and activity of vitiligo

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Serum concentration of the soluble interleukin-2 receptor in vitiligo patients

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Cross-presentation of self antigens to CD8+ T cells: the balance between tolerance and autoimmunity

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Activated B cells modified by electroporation of multiple mRNAs encoding immune stimulatory molecules are comparable to mature dendritic cells in inducing in vitro antigen-specific T-cell responses

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

A new role for an old player: do B cells unleash the self-reactive CD8+ T cell storm necessary for the development of type 1 diabetes?

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Expression of AIRE in thymocytes and peripheral lymphocytes

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

AIRE regulates T-cell-independent B-cell responses through BAFF.

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

The autoimmune regulator gene (AIRE) is strongly associated with vitiligo

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

Targeting of BAFF and APRIL for autoimmunity and oncology

26 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.10.034

26 August 2024

Identifiers

DOI

1 reference

14 September 2017

1 reference